Nucleic Acid Amplification Test (NAAT) PCR Diagnostic Kit Procurement for Assam Healthcare

Work Description - NA

This tender presents a vital procurement opportunity for the Health and Family Welfare Department, Assam, through the Assam Medical Services Corporation Limited. Under Bid Number GEM/2026/B/7957117, the organization is seeking to acquire 25,000 units of Nucleic Acid Amplification Test (NAAT) based PCR Diagnostic Kits for Human Samples (Q2). This procurement, specifically designated as PAC Only, is scheduled to commence on August 24, 2026, at 7:12 PM and will conclude on September 3, 2026, at 8:00 PM. Bidders are required to submit an Earnest Money Deposit (EMD) of ₹358,400.00. The tender originates from the Central Drug Warehouse located at Narengi, Guwahati, under the jurisdiction of the Ministry/State of Assam. This critical acquisition aims to bolster diagnostic capabilities within the state's healthcare infrastructure, ensuring timely and accurate identification of various conditions requiring NAAT-based PCR testing.